Crigler-Najjar syndrome type 2 (Q91609): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank

Revision as of 18:38, 15 August 2026

Type 2 Crigler-Najjar syndrome is a hereditary disorder of bilirubin metabolism characterised by unconjugated hyperbilirubinemia due to reduced and inducible activity of hepatic bilirubin glucuronosyltransferase (GT). CNS2 is a milder form of CNS than CNS1 (see these terms). First clinical manifestations usually appear soon after birth. CNS2 patients are less severely jaundiced than CNS1 patients, have pigmented bile that contains bilirubin glucuronides, and generally do not present neurologic or intellectual impairment. Bilirubin encephalopathy may develop in later life when patients experience a superimposed infection or stress.
Language Label Description Also known as
default for all languages
ID_846453488
    English
    Crigler-Najjar syndrome type 2
    Type 2 Crigler-Najjar syndrome is a hereditary disorder of bilirubin metabolism characterised by unconjugated hyperbilirubinemia due to reduced and inducible activity of hepatic bilirubin glucuronosyltransferase (GT). CNS2 is a milder form of CNS than CNS1 (see these terms). First clinical manifestations usually appear soon after birth. CNS2 patients are less severely jaundiced than CNS1 patients, have pigmented bile that contains bilirubin glucuronides, and generally do not present neurologic or intellectual impairment. Bilirubin encephalopathy may develop in later life when patients experience a superimposed infection or stress.

      Statements

      CID11:ID_846453488
      0 references
      dki-india-ID_846453488
      0 references
      Concluído
      0 references